Michael J Hearn

Title: Michael J Hearn: Innovator in Antimycobacterial Compounds

Introduction

Michael J Hearn is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of antimycobacterial compounds, holding two patents that showcase his innovative work. His research focuses on developing novel therapeutic agents that can aid in drug discovery.

Latest Patents

Hearn's latest patents include "Antimycobacterial compounds and method for making the same." This invention relates to novel antimycobacterial compounds, particularly those comprised of Schiff base, diacylhydrazine, sulfur-containing diacylhydrazine, and oxadiazoline congeners of isonicotinic acid hydrazide. The patent also details processes for their preparation, intermediates useful in their preparation, and their application as therapeutic agents in pharmaceutical compositions.

Another significant patent is "Derivatives of phenyl 4-aminosalicylate and method of making the same." This invention focuses on novel antimycobacterial compounds made from derivatives of phenyl 4-aminosalicylate. It outlines methods for their preparation and their use as therapeutic agents, emphasizing the production of these derivatives on a multi-gram scale with high purity for biological evaluation in drug discovery.

Career Highlights

Michael J Hearn is affiliated with Wellesley College, where he contributes to research and innovation in the field of medicinal chemistry. His work has been instrumental in advancing the understanding and development of antimycobacterial therapies.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Michael J Hearn's contributions to the field of antimycobacterial compounds highlight his innovative spirit and dedication to advancing therapeutic solutions. His patents reflect a commitment to improving drug discovery processes and developing effective treatments.